Evidence map›Paper›PMID 20935486›Full record

ArticleEpigenetics2011

CpG island chromatin: a platform for gene regulation.

Neil P Blackledge, Robert Klose

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Roles of transposable elements and DNA methylation in the formation of CpG islands and CpG-depleted regulatory elements.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Harnessing the Role ofInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Epigenomic insights into common human disease pathology.Cellular and molecular life sciences : CMLS · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Neil P BlackledgeDepartment of Biochemistry, University of Oxford, Oxford, UK.
Robert Klose
University of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The majority of mammalian gene promoters are encompassed within regions of the genome called CpG islands that have an elevated level of non-methylated CpG dinucleotides. Despite over 20 years of study, the precise mechanisms by which CpG islands contribute to regulatory element function remain poorly understood. Recently it has been demonstrated that specific histone modifying enzymes are recruited directly to CpG islands through recognition of non-methylated CpG dinucleotide sequence. These enzymes then impose unique chromatin architecture on CpG islands that distinguish them from the surrounding genome. In the context of this work we discuss how CpG island elements may contribute to the function of gene regulatory elements through the utilization of chromatin and epigenetic processes.

Indexed as

Epigenesis, GeneticAnimalsBase SequenceChromatinCpG IslandsDNA-Binding ProteinsDNA MethylationF-Box ProteinsGene Expression RegulationGene SilencingGenomeHistone DemethylasesHistonesHumansJumonji Domain-Containing Histone DemethylasesOxidoreductases, N-DemethylatingChromatinCXXC1 protein, humanDNA-Binding ProteinsF-Box ProteinsHistone DemethylasesHistonesJumonji Domain-Containing Histone DemethylasesKDM2A protein, humanOxidoreductases, N-DemethylatingTrans-Activators

Identifiers

PMID20935486
PMCPMC3278783
OpenAlexW2026487457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.